ArticleOpen forum infectious diseases2019

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis.

Maria R Ciardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.